Tocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer Trials – Xconomy
Xconomy |
Tocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer Trials
Xconomy Tocagen raised $85 million in its stock market debut today, and underwriters saw enough demand to increase the number of shares in the initial public offering. Tocagen has been developing a gene therapy treatment for a deadly type of brain cancer. Gene therapy company Tocagen prices offering at low end of range … |
